Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2019 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2019 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Investigation of the underling mechanism of ketamine for antidepressant effects in treatment‑refractory affective disorders via molecular profile analysis

  • Authors:
    • Jun Qiao
    • Yuan Sun
    • Jinfang Wu
    • Li Wang
  • View Affiliations / Copyright

    Affiliations: Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, Department of Anesthesiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, Department of Anesthesia Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China
    Copyright: © Qiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
  • Pages: 580-588
    |
    Published online on: May 30, 2019
       https://doi.org/10.3892/etm.2019.7633
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Ketamine elicits a rapid antidepressant effect in treatment‑refractory affective disorders. The aim of the present study was to elucidate the underlying mechanism of this effect and to identify potential targets of ketamine for antidepressant effects. GSE73798 and GSE73799 datasets were downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified in hippocampus or striatum samples treated with ketamine, phencyclidyne or memantine compared with a saline or normal group at 1, 2, 4 and 8 h. The overlapping DEGs were the DEGs in both hippocampus and striatum samples. Kyoto Encyclopedia of Genes and Genomes and BioCyc databases were used to perform functional annotation and pathway analyses. Protein‑protein interactions (PPIs) were predicted using Search Tool for the Retrieval of Interacting Genes/Proteins version 9.1 for the DEGs in the striatum samples treated with ketamine, phencyclidine or memantine compared with normal samples. Reverse transcription‑quantitative polymerase chain reaction was performed to determine mRNA levels. Perilipin 4 (Plin4), serum/glucocorticoid regulated kinase 1 (Sgk1), kruppel like factor 2 (Klf2) and DDB1 and CUL4 associated factor 12 like 1 (Dcaf12l1) were the overlapping DEGs in the striatum samples treated with the three drugs at different time points. The mRNA expression levels of Plin4, Sgk1 and Klf2 were significantly higher (P<0.05), and the mRNA expression level of Dcaf12l1 was significantly lower in the striatum samples of the ketamine‑treated group compared with the control group in an in vivo experiment. Both Sgk1 and Klf2 were enriched in the ‘forkhead box O (FoxO) signaling pathway’, and Sgk1 was additionally enriched in the ‘mechanistic target of rapamycin kinase (mTOR) signaling pathway’. PPI networks of DEGs in the striatum samples treated with ketamine, phencyclidine and memantine compared with normal samples were constructed, and Klf2 was involved in more pairs and was therefore a gene hub in the three networks. The four genes, Plin4, Sgk1, Klf2 and Dcaf12l1, were differentially expressed in all of the groups that treated with the three drugs and their expression levels were verified in in vivo experiments. The FoxO and mTOR signaling pathways may be involved in the underlying mechanism of the antidepressant effects of ketamine, and Plin4, Sgk1, Klf2 and Dcaf12l1 may be potential biomarkers for depression in N‑methyl‑D‑aspartic acid receptor antagonist treatment.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Saadat M, Behboodi ZM and Saadat E: Comparison of depression, anxiety, stress, and related factors among women and men with human immunodeficiency virus infection. J Hum Reprod Sci. 8:48–51. 2015. View Article : Google Scholar : PubMed/NCBI

2 

HM, Vega WA, Williams DR, Tarraf W, West BT and Neighbors HW: Depression care in the United States: too little for too few. Arch Gen Psychiatry. 67:37–46. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Krishnan V and Nestler EJ: The molecular neurobiology of depression. Nature. 455:894–902. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Mata DA, Ramos MA, Bansal N, Khan R, Guille C, Di Angelantonio E and Sen S: Prevalence of depression and depressive symptoms among resident physicians: A systematic review and meta-analysis. JAMA. 314:2373–2383. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Davey CG, Yücel M and Allen NB: The emergence of depression in adolescence: Development of the prefrontal cortex and the representation of reward. Neurosci Biobehav Rev. 32:1–19. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL and Azorin JM; avec le soutien institutionnel du laboratoire Lilly, : Drawing up guidelines for the attendance of physical health of patients with severe mental illness. Encéphale. 35:330–339. 2009.(In French). View Article : Google Scholar

7 

Rogers D and Pies R: General medical with depression drugs associated. Psychiatry (Edgmont). 5:28–41. 2008.PubMed/NCBI

8 

Al-Harbi KS: Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 6:369–388. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Aiyer R, Mehta N, Gungor S and Gulati A: A systematic review of NMDA receptor antagonists for treatment of neuropathic pain in clinical practice. Clin J Pain. 34:450–467. 2018.PubMed/NCBI

10 

Leung LS and Ma J: Medial septum modulates hippocampal gamma activity and prepulse inhibition in an, N-methyl-d-aspartate receptor antagonist model of schizophrenia. Schizophr Res. 198:36–44. 2018. View Article : Google Scholar : PubMed/NCBI

11 

Rasmussen KG: Psychiatric side effects of ketamine in hospitalized medical patients administered subanesthetic doses for pain control. Acta Neuropsychiatr. 26:230–233. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Ceber M and Salihoglu T: Ketamine may be the first choice for anesthesia in burn patients. J Burn Care Res. 27:760–762. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Heshmati F, Zeinali MB, Noroozinia H, Abbacivash R and Mahoori A: Use of ketamine in severe status asthmaticus in intensive care unit. Iran J Allergy Asthma Immunol. 2:175–180. 2003.PubMed/NCBI

14 

Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G and Manji HK: Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 63:349–352. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS and Iosifescu DV: Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 74:250–256. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Ardalan M, Rafati AH, Nyengaard JR and Wegener G: Rapid antidepressant effect of ketamine correlates with astroglial plasticity in the hippocampus. Br J Pharmacol. 174:483–492. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Jing XU: The establishment and evaluation of chronic unpredictable mild stress depression model. Chin J Behavioral Med Sci. 12:14–17. 2003.(In Chinese).

18 

Wang J, Goffer Y, Xu D, Tukey DS, Shamir DB, Eberle SE, Zou AH, Blanck TJ and Ziff EB: A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology. 115:812–821. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

20 

Meijerink J, Mandigers C, van de Locht L, Tönnissen E, Goodsaid F and Raemaekers J: A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative Real-Time PCR. J Mol Diagn. 3:55–61. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Corrales E, Navarro A, Cuenca P and Campos D: Candidate gene study reveals DRD1 and DRD2 as putative interacting risk factors for youth depression. Psychiatry Res. 244:71–77. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Lacerda-Pinheiro SF, Pinheiro Junior RF, Pereira de Lima MA, Lima da Silva CG, Vieira dos Santos Mdo S, Teixeira Júnior AG, Lima de Oliveira PN, Ribeiro KD, Rolim-Neto ML and Bianco BA: Are there depression and anxiety genetic markers and mutations? A systematic review. J Affect Disord. 168:387–398. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Gadow KD, Smith RM and Pinsonneault JK: Serotonin 2A receptor gene (HTR2A) regulatory variants: Possible association with severity of depression symptoms in children with autism spectrum disorder. Cogn Behav Neurol. 27:107–116. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Milanesi E, Bonvicini C, Congiu C, Bortolomasi M, Gainelli G, Gennarelli M and Minelli A: The role of GRIK4 gene in treatment-resistant depression. Genet Res (Camb). 97:e142015. View Article : Google Scholar : PubMed/NCBI

25 

Wolins NE, Quaynor BK, Skinner JR, Schoenfish MJ, Tzekov A and Bickel PE: S3-12, Adipophilin, and TIP47 package lipid in adipocytes. J Biol Chem. 280:19146–19155. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Chen W, Chang B, Wu X, Li L, Sleeman M and Chan L: Inactivation of Plin4 downregulates Plin5 and reduces cardiac lipid accumulation in mice. Am J Physiol Endocrinol Metab. 304:E770–E779. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Peters SJ, Samjoo IA, Devries MC, Stevic I, Robertshaw HA and Tarnopolsky MA: Perilipin family (PLIN) proteins in human skeletal muscle: The effect of sex, obesity, and endurance training. Appl Physiol Nutr Metab. 37:724–735. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Soenen S, Mariman EC, Vogels N, Bouwman FG, den Hoed M, Brown L and Westerterp-Plantenga MS: Relationship between perilipin gene polymorphisms and body weight and body composition during weight loss and weight maintenance. Physiol Behav. 96:723–728. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Schoenebeck B, Bader V, Zhu XR, Schmitz B, Lübbert H and Stichel CC: Sgk1, a cell survival response in neurodegenerative diseases. Mol Cell Neurosci. 30:249–264. 2005. View Article : Google Scholar : PubMed/NCBI

30 

Anacker C, Cattaneo A, Musaelyan K, Zunszain PA, Horowitz M, Molteni R, Luoni A, Calabrese F, Tansey K, Gennarelli M, et al: Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc Natl Acad Sci USA. 110:8708–8713. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Pearson R, Fleetwood J, Eaton S, Crossley M and Bao S: Kruppel-like transcription factors: A functional family. Int J Biochem Cell Biol. 40:1996–2001. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Miller OH, Grabole N, Wells I and Hall J: Genome-wide translating mRNA analysis following ketamine reveals novel targets for antidepressant treatment. BioRxiv. 2018.

33 

Ramasamy R, Ridgeway A, Lipshultz LI and Lamb DJ: Integrative DNA methylation and gene expression analysis identifies discoidin domain receptor 1 association with idiopathic nonobstructive azoospermia. Fertil Steril. 102:968–973.e3. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Gerovska D and Arauzo-Bravo MJ: Does mouse embryo primordial germ cell activation start before implantation as suggested by single-cell transcriptomics dynamics? Mol Hum Reprod. 22:208–225. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Duman RS, Li N, Liu RJ, Duric V and Aghajanian G: Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology. 62:35–41. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G and Duman RS: mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 329:959–964. 2010. View Article : Google Scholar : PubMed/NCBI

37 

Ficek J, Zygmunt M, Piechota M, Hoinkis D, Rodriguez Parkitna J, Przewlocki R and Korostynski M: Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action. BMC Genomics. 17:3622016. View Article : Google Scholar : PubMed/NCBI

38 

Farhan M, Wang H, Gaur U, Little PJ, Xu J and Zheng W: FOXO signaling pathways as therapeutic targets in cancer. Int J Biol Sci. 13:815–827. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Polter A, Yang S, Zmijewska AA, van Groen T, Paik JH, Depinho RA, Peng SL, Jope RS and Li X: Forkhead box, class O transcription factors in brain: Regulation and behavioral manifestation. Biol Psychiatry. 65:150–159. 2009. View Article : Google Scholar : PubMed/NCBI

40 

Farhan M, Wang H, Gaur U, Little PJ, Xu J and Zheng W: FOXO signaling pathways as therapeutic targets in cancer. Int J Biol Sci. 13:815–827. 2017. View Article : Google Scholar : PubMed/NCBI

41 

Huang P, Zhou Z, Shi F, Shao G, Wang R, Wang J, Wang K and Ding W: Effects of the IGF-1/PTEN/Akt/FoxO signaling pathway on male reproduction in rats subjected to water immersion and restraint stress. Mol Med Rep. 14:5116–5124. 2016. View Article : Google Scholar : PubMed/NCBI

42 

Liang B, Moussaif M, Kuan CJ, Gargus JJ and Sze JY: Serotonin targets the DAF-16/FOXO signaling pathway to modulate stress responses. Cell Metab. 4:429–440. 2006. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Qiao J, Sun Y, Wu J and Wang L: Investigation of the underling mechanism of ketamine for antidepressant effects in treatment‑refractory affective disorders via molecular profile analysis. Exp Ther Med 18: 580-588, 2019.
APA
Qiao, J., Sun, Y., Wu, J., & Wang, L. (2019). Investigation of the underling mechanism of ketamine for antidepressant effects in treatment‑refractory affective disorders via molecular profile analysis. Experimental and Therapeutic Medicine, 18, 580-588. https://doi.org/10.3892/etm.2019.7633
MLA
Qiao, J., Sun, Y., Wu, J., Wang, L."Investigation of the underling mechanism of ketamine for antidepressant effects in treatment‑refractory affective disorders via molecular profile analysis". Experimental and Therapeutic Medicine 18.1 (2019): 580-588.
Chicago
Qiao, J., Sun, Y., Wu, J., Wang, L."Investigation of the underling mechanism of ketamine for antidepressant effects in treatment‑refractory affective disorders via molecular profile analysis". Experimental and Therapeutic Medicine 18, no. 1 (2019): 580-588. https://doi.org/10.3892/etm.2019.7633
Copy and paste a formatted citation
x
Spandidos Publications style
Qiao J, Sun Y, Wu J and Wang L: Investigation of the underling mechanism of ketamine for antidepressant effects in treatment‑refractory affective disorders via molecular profile analysis. Exp Ther Med 18: 580-588, 2019.
APA
Qiao, J., Sun, Y., Wu, J., & Wang, L. (2019). Investigation of the underling mechanism of ketamine for antidepressant effects in treatment‑refractory affective disorders via molecular profile analysis. Experimental and Therapeutic Medicine, 18, 580-588. https://doi.org/10.3892/etm.2019.7633
MLA
Qiao, J., Sun, Y., Wu, J., Wang, L."Investigation of the underling mechanism of ketamine for antidepressant effects in treatment‑refractory affective disorders via molecular profile analysis". Experimental and Therapeutic Medicine 18.1 (2019): 580-588.
Chicago
Qiao, J., Sun, Y., Wu, J., Wang, L."Investigation of the underling mechanism of ketamine for antidepressant effects in treatment‑refractory affective disorders via molecular profile analysis". Experimental and Therapeutic Medicine 18, no. 1 (2019): 580-588. https://doi.org/10.3892/etm.2019.7633
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team